Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1995 4
1996 12
1997 7
1998 11
1999 11
2000 27
2001 26
2002 34
2003 36
2004 43
2005 24
2006 36
2007 31
2008 46
2009 49
2010 42
2011 31
2012 35
2013 26
2014 31
2015 17
2016 20
2017 18
2018 18
2019 20
2020 26
2021 17
2022 22
2023 20
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

701 results

Results by year

Filters applied: . Clear all
Page 1
Cost-effectiveness of latanoprost and timolol maleate for the treatment of glaucoma in Scandinavia and the United Kingdom, using a decision-analytic health economic model.
Stewart WC, Stewart JA, Mychaskiw MA. Stewart WC, et al. Eye (Lond). 2009 Jan;23(1):132-40. doi: 10.1038/sj.eye.6702964. Epub 2007 Aug 24. Eye (Lond). 2009. PMID: 17721497 Review.
PURPOSE: To assess the cost-effectiveness of latanoprost or timolol in glaucoma treatment in Norway, Sweden, Denmark (Scandinavia) and the United Kingdom (UK). ...CONCLUSIONS: Over 5 years, in the UK timolol is the cost-effective option, whereas in Scandinavi …
PURPOSE: To assess the cost-effectiveness of latanoprost or timolol in glaucoma treatment in Norway, Sweden, Denmark (Scandina …
Comparative evaluation of Latanoprostene Bunod, Timolol Maleate, and latanoprost Ophthalmic Solutions to assess their safety and efficacy in lowering intraocular pressure for the management of Open-Angle Glaucoma.
Wang Y, Liao Y, Nie X. Wang Y, et al. Clinics (Sao Paulo). 2020 Nov 30;75:e1874. doi: 10.6061/clinics/2020/e1874. eCollection 2020. Clinics (Sao Paulo). 2020. PMID: 33263632 Free PMC article.
OBJECTIVES: Timolol maleate has been reported to be a safer intraocular pressure (IOP) lowering treatment than latanoprost. The United States Food and Drug Administration approved latanoprostene bunod, a nitric oxide-donating prodrug of latanoprost, fo …
OBJECTIVES: Timolol maleate has been reported to be a safer intraocular pressure (IOP) lowering treatment than latanoprost …
Efficacy of latanoprost and timolol maleate in black and white patients.
Kitnarong N, Zhao Y, Netland PA, Kent AR. Kitnarong N, et al. Adv Ther. 2004 Jul-Aug;21(4):203-13. doi: 10.1007/BF02850153. Adv Ther. 2004. PMID: 15605615 Clinical Trial.
The purpose of this study was to assess the efficacy of latanoprost 0.005% and timolol maleate 0.5% in black and white patients with elevated intraocular pressure (IOP). ...After a 2- to 4-week washout period, patients were randomly assigned to receive either …
The purpose of this study was to assess the efficacy of latanoprost 0.005% and timolol maleate 0.5% in black and white …
Travoprost/timolol.
Hoy SM, Keam SJ, Keating GM. Hoy SM, et al. Drugs Aging. 2006;23(7):587-97; discussion 598-9. doi: 10.2165/00002512-200623070-00005. Drugs Aging. 2006. PMID: 16930087 Review.
Both travoprost/timolol and latanoprost plus timolol maintained IOP control, and travoprost/timolol was shown to be noninferior to latanoprost/timolol in randomised, well designed studies. Travoprost/timolol was generally well tole …
Both travoprost/timolol and latanoprost plus timolol maintained IOP control, and travoprost/timolol was shown to …
Latanoprost/timolol fixed combination for the treatment of glaucoma.
Konstas AG, Mocan MC, Katsanos A, Voudouragkaki IC, Irkec M. Konstas AG, et al. Expert Opin Pharmacother. 2013 Sep;14(13):1815-27. doi: 10.1517/14656566.2013.813482. Epub 2013 Jun 28. Expert Opin Pharmacother. 2013. PMID: 23806084 Review.
AREAS COVERED: Briefly discussed are selected, recent evidence on antiglaucoma fixed combinations. Then the efficacy and safety of the latanoprost/timolol fixed combination is comprehensively reviewed. EXPERT OPINION: The latanoprost/timolol fixed comb …
AREAS COVERED: Briefly discussed are selected, recent evidence on antiglaucoma fixed combinations. Then the efficacy and safety of the la …
Travoprost/timolol fixed combination.
Herceg M, Noecker R. Herceg M, et al. Expert Opin Pharmacother. 2008 Apr;9(6):1059-65. doi: 10.1517/14656566.9.6.1059. Expert Opin Pharmacother. 2008. PMID: 18377347 Review.
The fixed combination eye drop, Duotrav (travoprost 0.004% and timolol maleate 0.5%), has recently been introduced into the market. ...Studies selected for review compared efficacy and side-effect profile of fixed combination travoprost/timolol with travopros …
The fixed combination eye drop, Duotrav (travoprost 0.004% and timolol maleate 0.5%), has recently been introduced into the ma …
The Effects of Topical Timolol and Latanoprost on Calculated Ocular Perfusion Pressure in Nonglaucomatous Volunteers.
Kolli A, Toris CB, Reed DM, Gilbert J, Sit AJ, Gulati V, Kazemi A, Fan S, Musch DC, Moroi SE. Kolli A, et al. J Ocul Pharmacol Ther. 2021 Dec;37(10):565-574. doi: 10.1089/jop.2021.0068. Epub 2021 Oct 4. J Ocul Pharmacol Ther. 2021. PMID: 34610254 Free PMC article. Clinical Trial.
Purpose: To characterize the effects of timolol and latanoprost on calculated ocular perfusion pressure (OPP) in a multicenter, prospective, crossover-design study. ...When compared with baseline, OPP calculated with diastolic BP was significantly increased with bot …
Purpose: To characterize the effects of timolol and latanoprost on calculated ocular perfusion pressure (OPP) in a multicenter …
Combined therapy of pilocarpine or latanoprost with timolol versus latanoprost monotherapy.
Diestelhorst M, Nordmann JP, Toris CB. Diestelhorst M, et al. Surv Ophthalmol. 2002 Aug;47 Suppl 1:S155-61. doi: 10.1016/s0039-6257(02)00329-6. Surv Ophthalmol. 2002. PMID: 12204713 Review.
The IOP efficacy of combined therapy with timolol and pilocarpine compared with timolol and latanoprost or with latanoprost alone has been investigated in three multicenter, randomized, clinical trials in Europe. ...These 6-month studies found that the …
The IOP efficacy of combined therapy with timolol and pilocarpine compared with timolol and latanoprost or with lata …
The efficacy and safety of bimatoprost/timolol maleate, latanoprost/timolol maleate, and travoprost/timolol maleate fixed combinations on 24-h IOP.
Guven Yilmaz S, Degirmenci C, Karakoyun YE, Yusifov E, Ates H. Guven Yilmaz S, et al. Int Ophthalmol. 2018 Aug;38(4):1425-1431. doi: 10.1007/s10792-017-0601-8. Epub 2017 Jun 14. Int Ophthalmol. 2018. PMID: 28616797 Clinical Trial.
PURPOSE: To evaluate the effect of bimatoprost/timolol maleate fixed combination (BTFC), latanoprost/timolol maleate fixed combination (LTFC), and travoprost/timolol maleate fixed combination (TTFC) on 24-h intraocular pressure (IO …
PURPOSE: To evaluate the effect of bimatoprost/timolol maleate fixed combination (BTFC), latanoprost/timolol …
Co-delivery of latanoprost and timolol from micelles-laden contact lenses for the treatment of glaucoma.
Xu J, Ge Y, Bu R, Zhang A, Feng S, Wang J, Gou J, Yin T, He H, Zhang Y, Tang X. Xu J, et al. J Control Release. 2019 Jul 10;305:18-28. doi: 10.1016/j.jconrel.2019.05.025. Epub 2019 May 16. J Control Release. 2019. PMID: 31103677
CLs-M were obtained by free radical polymerization of HEMA monomer with timolol and latanoprost loaded mPEG-PLA micelles. The prepared CLs-M had a minimal impact on critical CLs properties, and could release timolol and latanoprost in simulated tear fl …
CLs-M were obtained by free radical polymerization of HEMA monomer with timolol and latanoprost loaded mPEG-PLA micelles. The …
701 results